Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, and Pembrolizumab for Advanced Melanoma: A Systematic Review a... by Abdulaali R. Almutairi, Abdulaali R. Almutairi, Ali McBride, Ali McBride, Marion Slack, Brian L. Erstad, Ivo Abraham, Ivo Abraham, Ivo Abraham

Get full text

Angiosarcoma treated successfully with anti-PD-1 therapy - a case report by Simran Sindhu, Lana H. Gimber, Lee Cranmer, Ali McBride, Andrew S. Kraft

Get full text

Association of immune-checkpoint inhibitors and the risk of immune-related colitis among elderly patients with advanced melanoma: real-world evidence from the SEER–Medicare databas... by Abdulaali R. Almutairi, Marion Slack, Brian L. Erstad, Ali McBride, Ivo Abraham

Get full text

Pentoxifylline and vitamin E drug compliance after adjuvant breast radiation therapy by Justin M. Famoso, MD, Brady Laughlin, BS, Ali McBride, PharmD MS, Victor J. Gonzalez, MD

Get full text

Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report by Ali McBride, Andrew J. Garcia, Lauren J. Sanders, Kelly Yiu, Lee D. Cranmer, Phillip H. Kuo, Matthew Kay, Andrew S. Kraft

Get full text

Treatment patterns and outcomes with luspatercept in patients with lower‐risk myelodysplastic syndromes: A retrospective US cohort analysis by Sudipto Mukherjee, Cherrishe Brown‐Bickerstaff, Angelica Falkenstein, Adeola Y. Makinde, Emily Bland, JaLyna Laney, Marné Garretson, David Huggar, Ali McBride

Get full text